China's National Healthcare Security Administration Launches Personal Medical Insurance Cloud Initiative; 18 Projects Worth Over $700M Tendered; Baichuan M3 Medical AI Model Open-Sourced; 12 Companies Raise $490M; Domestic Brain-Computer Interface Set for Mass Production
BAICHUAN AI
AI Medical Technology Researcher
NeuroXess
Invasive Brain-Computer Interface Developer
KingMed Diagnostics
Third-Party Medical Testing and Pathological Diagnosis Service Provider
Neuralink
Brain-Computer Interface System Developer
Industry Trends
BAICHUAN AI Open Sources New Generation Medical Large Model M3! C-end Applications to Be Launched This Year, IPO to Start in 2027On January 13, BAICHUAN AI announced the official open-sourcing of its new-generation medical large model, Baichuan-M3. The Baichuan M3 has achieved key breakthroughs in three aspects: clinical reasoning, hallucination control, and diagnostic capabilities. Reportedly, it ranked first globally with a comprehensive score of 65.1 in HealthBench, the world's most authoritative medical AI evaluation, and also topped the HealthBench Hard, which specifically tests complex decision-making abilities, with a score of 44.4. Meanwhile, Baichuan M3 achieved a medical hallucination rate of 3.5, the lowest globally, surpassing GPT-5.2 comprehensively in the medical field for the first time. During this technology release, Wang Xiaochuan, founder and CEO of BAICHUAN AI, revealed to the media that an IPO might be initiated two years later.
At the beginning of 2026, the brain-computer interface sector exploded in popularity. Recently, Elon Musk announced on social media that his brain-computer interface company Neuralink plans to begin large-scale mass production of brain-computer interface devices in 2026. On January 13, 2026, news also emerged in China about the upcoming mass production of brain-computer interfaces.
NeuroXess, founded in 2021, held the groundbreaking ceremony for its "Super Factory" project in the Ganjiang New Area of Jiangxi Province. NeuroXess stated that the project is expected to be completed and put into operation in the second half of 2026. This marks a crucial step forward in China’s advancement in this cutting-edge technology field, transitioning from laboratory research to large-scale production. Additionally, it will undertake the mass production of China's first domestically produced, fully implantable, wireless, and fully functional brain-computer interface — the world’s second of its kind. This project represents a strategic pivot for NeuroXess as it moves from "scientific breakthroughs in Shanghai" to establishing a "manufacturing loop in Jiangxi."
The Third Affiliated Hospital of Sun Yat-sen University Launches AI Doctor! Jointly Released by The Third Affiliated Hospital of Sun Yat-sen University, KingMed Diagnostics, and China Unicom Digital Healthcare
On January 9, the AI doctor of the Third Affiliated Hospital of Sun Yat-sen University, jointly developed by the Third Affiliated Hospital of Sun Yat-sen University, KingMed Diagnostics, and China Unicom Digital Intelligence Medical, was officially launched. This AI doctor, which is based on real inpatient cases and complete treatment pathways for reasoning, not only helps clinical doctors improve diagnostic efficiency but also promotes the distribution of high-level medical intelligence and resources to primary healthcare settings.
Reportedly, the AI Doctor is an auxiliary decision-making intelligent platform for clinical doctors. It deeply integrates the high-quality clinical cases accumulated over more than a decade and authoritative expert experience from the Third Affiliated Hospital of Sun Yat-sen University (Zhongshan SanYuan). The platform leverages digital infrastructure and computing power from Digital Intelligence Healthcare, as well as the multi-agent evidence-based medical reasoning engine from KingMed Diagnostics. It has been trained using over 1.3 million anonymized real-world treatment data entries, more than 700,000 clinical case reports, over 2,000 authoritative domestic and international guidelines and expert consensuses, and an 8-million-node OMAHA medical knowledge graph along with the KingMed Diagnostics Laboratory Knowledge Base. The system covers the entire chain of diagnosis and treatment from "symptoms - examination - diagnosis - treatment - follow-up" and effectively avoids black-box conclusions.
Industry Trends
BAICHUAN AI Open Sources New Generation Medical Large Model M3! C-end Applications to Be Launched This Year, IPO to Start in 2027On January 13, BAICHUAN AI announced the official open-sourcing of its new-generation medical large model, Baichuan-M3. The Baichuan M3 has achieved key breakthroughs in three aspects: clinical reasoning, hallucination control, and diagnostic capabilities. Reportedly, it ranked first globally with a comprehensive score of 65.1 in HealthBench, the world's most authoritative medical AI evaluation, and also topped the HealthBench Hard, which specifically tests complex decision-making abilities, with a score of 44.4. Meanwhile, Baichuan M3 achieved a medical hallucination rate of 3.5, the lowest globally, surpassing GPT-5.2 comprehensively in the medical field for the first time. During this technology release, Wang Xiaochuan, founder and CEO of BAICHUAN AI, revealed to the media that an IPO might be initiated two years later.
At the beginning of 2026, the brain-computer interface sector exploded in popularity. Recently, Elon Musk announced on social media that his brain-computer interface company Neuralink plans to begin large-scale mass production of brain-computer interface devices in 2026. On January 13, 2026, news also emerged in China about the upcoming mass production of brain-computer interfaces.
NeuroXess, founded in 2021, held the groundbreaking ceremony for its "Super Factory" project in the Ganjiang New Area of Jiangxi Province. NeuroXess stated that the project is expected to be completed and put into operation in the second half of 2026. This marks a crucial step forward in China’s advancement in this cutting-edge technology field, transitioning from laboratory research to large-scale production. Additionally, it will undertake the mass production of China's first domestically produced, fully implantable, wireless, and fully functional brain-computer interface — the world’s second of its kind. This project represents a strategic pivot for NeuroXess as it moves from "scientific breakthroughs in Shanghai" to establishing a "manufacturing loop in Jiangxi."
The Third Affiliated Hospital of Sun Yat-sen University Launches AI Doctor! Jointly Released by The Third Affiliated Hospital of Sun Yat-sen University, KingMed Diagnostics, and China Unicom Digital Healthcare
On January 9, the AI doctor of the Third Affiliated Hospital of Sun Yat-sen University, jointly developed by the Third Affiliated Hospital of Sun Yat-sen University, KingMed Diagnostics, and China Unicom Digital Intelligence Medical, was officially launched. This AI doctor, which is based on real inpatient cases and complete treatment pathways for reasoning, not only helps clinical doctors improve diagnostic efficiency but also promotes the distribution of high-level medical intelligence and resources to primary healthcare settings.
Reportedly, the AI Doctor is an auxiliary decision-making intelligent platform for clinical doctors. It deeply integrates the high-quality clinical cases accumulated over more than a decade and authoritative expert experience from the Third Affiliated Hospital of Sun Yat-sen University (Zhongshan SanYuan). The platform leverages digital infrastructure and computing power from Digital Intelligence Healthcare, as well as the multi-agent evidence-based medical reasoning engine from KingMed Diagnostics. It has been trained using over 1.3 million anonymized real-world treatment data entries, more than 700,000 clinical case reports, over 2,000 authoritative domestic and international guidelines and expert consensuses, and an 8-million-node OMAHA medical knowledge graph along with the KingMed Diagnostics Laboratory Knowledge Base. The system covers the entire chain of diagnosis and treatment from "symptoms - examination - diagnosis - treatment - follow-up" and effectively avoids black-box conclusions.
On January 13, BAICHUAN AI announced the official open-sourcing of its new-generation medical large model, Baichuan-M3. The Baichuan M3 has achieved key breakthroughs in three aspects: clinical reasoning, hallucination control, and diagnostic capabilities. Reportedly, it ranked first globally with a comprehensive score of 65.1 in HealthBench, the world's most authoritative medical AI evaluation, and also topped the HealthBench Hard, which specifically tests complex decision-making abilities, with a score of 44.4. Meanwhile, Baichuan M3 achieved a medical hallucination rate of 3.5, the lowest globally, surpassing GPT-5.2 comprehensively in the medical field for the first time. During this technology release, Wang Xiaochuan, founder and CEO of BAICHUAN AI, revealed to the media that an IPO might be initiated two years later.
At the beginning of 2026, the brain-computer interface sector exploded in popularity. Recently, Elon Musk announced on social media that his brain-computer interface company Neuralink plans to begin large-scale mass production of brain-computer interface devices in 2026. On January 13, 2026, news also emerged in China about the upcoming mass production of brain-computer interfaces.
NeuroXess, founded in 2021, held the groundbreaking ceremony for its "Super Factory" project in the Ganjiang New Area of Jiangxi Province. NeuroXess stated that the project is expected to be completed and put into operation in the second half of 2026. This marks a crucial step forward in China’s advancement in this cutting-edge technology field, transitioning from laboratory research to large-scale production. Additionally, it will undertake the mass production of China's first domestically produced, fully implantable, wireless, and fully functional brain-computer interface — the world’s second of its kind. This project represents a strategic pivot for NeuroXess as it moves from "scientific breakthroughs in Shanghai" to establishing a "manufacturing loop in Jiangxi."
The Third Affiliated Hospital of Sun Yat-sen University Launches AI Doctor! Jointly Released by The Third Affiliated Hospital of Sun Yat-sen University, KingMed Diagnostics, and China Unicom Digital Healthcare
On January 9, the AI doctor of the Third Affiliated Hospital of Sun Yat-sen University, jointly developed by the Third Affiliated Hospital of Sun Yat-sen University, KingMed Diagnostics, and China Unicom Digital Intelligence Medical, was officially launched. This AI doctor, which is based on real inpatient cases and complete treatment pathways for reasoning, not only helps clinical doctors improve diagnostic efficiency but also promotes the distribution of high-level medical intelligence and resources to primary healthcare settings.
Reportedly, the AI Doctor is an auxiliary decision-making intelligent platform for clinical doctors. It deeply integrates the high-quality clinical cases accumulated over more than a decade and authoritative expert experience from the Third Affiliated Hospital of Sun Yat-sen University (Zhongshan SanYuan). The platform leverages digital infrastructure and computing power from Digital Intelligence Healthcare, as well as the multi-agent evidence-based medical reasoning engine from KingMed Diagnostics. It has been trained using over 1.3 million anonymized real-world treatment data entries, more than 700,000 clinical case reports, over 2,000 authoritative domestic and international guidelines and expert consensuses, and an 8-million-node OMAHA medical knowledge graph along with the KingMed Diagnostics Laboratory Knowledge Base. The system covers the entire chain of diagnosis and treatment from "symptoms - examination - diagnosis - treatment - follow-up" and effectively avoids black-box conclusions.
Heavyweight Policy
Heavyweight Policy
On January 11, the Office of the National Healthcare Security Administration released the "Notice on Launching the Pilot Application for the Construction of Personal Medical Insurance Cloud." It proposed to build provincial (municipal) personal medical insurance clouds based on a unified national medical insurance information platform, driven by data elements as the core. Following the construction path of "element aggregation, resource integration, intelligent application, and multi-party empowerment," the initiative aims to gather, manage, and apply multi-dimensional personal medical insurance health data. This will precisely create a personal medical insurance profile that includes health records, financial records, and information records, transforming them into intelligent services that insured individuals can access and experience. The project will support the development of new medical services, smart elderly care, health insurance, and other industries while accumulating experience for the digital and intelligent development of healthcare security in China.
The goal is to form a number of scientifically structured, data-rich, and highly effective application models for the construction and operation of personal medical insurance clouds through pilot projects. Gradually expand the coverage of medical insurance health data across all times, regions, dimensions, and the entire life cycle, and create a number of highly demonstrative "artificial intelligence + medical security" application scenarios.
National Healthcare Security Administration: The Medical Insurance Drug Price Comparison Mini-Program Launches Nationwide in China, No More Wasted Money on Medications!
On January 16, according to the National Healthcare Security Administration, all 31 provinces (regions, municipalities) and the Xinjiang Production and Construction Corps in China have completed the launch of the mini-program, achieving full regional coverage and universal accessibility, allowing insured individuals across the country to enjoy convenient price comparison services. It is reported that the healthcare security drug price comparison mini-program relies on data resources from designated medical institutions nationwide, featuring timely data updates, comprehensive functions, and extensive coverage, enabling one-stop pharmaceutical price inquiries.
Hangzhou's "15th Five-Year Plan" Recommendations: Advancing the Medical Foundation Strengthening Project, Building a Billion-Dollar Pharmaceutical and Medical Device Industry Cluster, and Establishing the "First City" of AI!
On January 11, the Office of the National Healthcare Security Administration released the "Notice on Launching the Pilot Application for the Construction of Personal Medical Insurance Cloud." It proposed to build provincial (municipal) personal medical insurance clouds based on a unified national medical insurance information platform, driven by data elements as the core. Following the construction path of "element aggregation, resource integration, intelligent application, and multi-party empowerment," the initiative aims to gather, manage, and apply multi-dimensional personal medical insurance health data. This will precisely create a personal medical insurance profile that includes health records, financial records, and information records, transforming them into intelligent services that insured individuals can access and experience. The project will support the development of new medical services, smart elderly care, health insurance, and other industries while accumulating experience for the digital and intelligent development of healthcare security in China.
The goal is to form a number of scientifically structured, data-rich, and highly effective application models for the construction and operation of personal medical insurance clouds through pilot projects. Gradually expand the coverage of medical insurance health data across all times, regions, dimensions, and the entire life cycle, and create a number of highly demonstrative "artificial intelligence + medical security" application scenarios.
National Healthcare Security Administration: The Medical Insurance Drug Price Comparison Mini-Program Launches Nationwide in China, No More Wasted Money on Medications!
On January 16, according to the National Healthcare Security Administration, all 31 provinces (regions, municipalities) and the Xinjiang Production and Construction Corps in China have completed the launch of the mini-program, achieving full regional coverage and universal accessibility, allowing insured individuals across the country to enjoy convenient price comparison services. It is reported that the healthcare security drug price comparison mini-program relies on data resources from designated medical institutions nationwide, featuring timely data updates, comprehensive functions, and extensive coverage, enabling one-stop pharmaceutical price inquiries.
Hangzhou's "15th Five-Year Plan" Recommendations: Advancing the Medical Foundation Strengthening Project, Building a Billion-Dollar Pharmaceutical and Medical Device Industry Cluster, and Establishing the "First City" of AI!
National Healthcare Security Administration: The Medical Insurance Drug Price Comparison Mini-Program Launches Nationwide in China, No More Wasted Money on Medications!
National Healthcare Security Administration: The Medical Insurance Drug Price Comparison Mini-Program Launches Nationwide in China, No More Wasted Money on Medications!
On January 16, according to the National Healthcare Security Administration, all 31 provinces (regions, municipalities) and the Xinjiang Production and Construction Corps in China have completed the launch of the mini-program, achieving full regional coverage and universal accessibility, allowing insured individuals across the country to enjoy convenient price comparison services. It is reported that the healthcare security drug price comparison mini-program relies on data resources from designated medical institutions nationwide, featuring timely data updates, comprehensive functions, and extensive coverage, enabling one-stop pharmaceutical price inquiries.
Hangzhou's "15th Five-Year Plan" Recommendations: Advancing the Medical Foundation Strengthening Project, Building a Billion-Dollar Pharmaceutical and Medical Device Industry Cluster, and Establishing the "First City" of AI!
Hangzhou's "15th Five-Year Plan" Recommendations: Advancing the Medical Foundation Strengthening Project, Building a Billion-Dollar Pharmaceutical and Medical Device Industry Cluster, and Establishing the "First City" of AI!
On January 9, the People's Government of Hubei Province issued the "Implementation Plan for Building a Smart Modern Medical System," systematically planning four major tasks and 18 measures. It clearly states that by 2027, a smart modern medical system covering the entire province will be basically completed. In terms of smart hospital construction, by the end of 2026, all tertiary hospitals will achieve full coverage of seven digital and intelligent medical scenarios, including AI cloud accompaniment, self-service order placement for tests and examinations, cross-institution mutual recognition of test results, and smart pharmacies.
Recently, the People's Government of Jiangsu Province issued the "Jiangsu Province 'Artificial Intelligence+' Action Plan," proposing to popularize intelligent medical and health services. It aims to promote the integration and application of large models in clinical diagnosis and treatment, disease prevention, primary healthcare, traditional Chinese medicine services, childcare and elderly care, medical management, and medical insurance scenarios. A multi-level, multi-modal, high-quality medical and health dataset covering the entire life cycle will be developed. Efforts will also accelerate the construction of Medical Health Digital Intelligence Innovation Labs, Medical Insurance Data Empowerment Labs, and Trusted Data Spaces for the Health and Medical Insurance industries.
On January 9, the People's Government of Hubei Province issued the "Implementation Plan for Building a Smart Modern Medical System," systematically planning four major tasks and 18 measures. It clearly states that by 2027, a smart modern medical system covering the entire province will be basically completed. In terms of smart hospital construction, by the end of 2026, all tertiary hospitals will achieve full coverage of seven digital and intelligent medical scenarios, including AI cloud accompaniment, self-service order placement for tests and examinations, cross-institution mutual recognition of test results, and smart pharmacies.
Recently, the People's Government of Jiangsu Province issued the "Jiangsu Province 'Artificial Intelligence+' Action Plan," proposing to popularize intelligent medical and health services. It aims to promote the integration and application of large models in clinical diagnosis and treatment, disease prevention, primary healthcare, traditional Chinese medicine services, childcare and elderly care, medical management, and medical insurance scenarios. A multi-level, multi-modal, high-quality medical and health dataset covering the entire life cycle will be developed. Efforts will also accelerate the construction of Medical Health Digital Intelligence Innovation Labs, Medical Insurance Data Empowerment Labs, and Trusted Data Spaces for the Health and Medical Insurance industries.
Recently, the People's Government of Jiangsu Province issued the "Jiangsu Province 'Artificial Intelligence+' Action Plan," proposing to popularize intelligent medical and health services. It aims to promote the integration and application of large models in clinical diagnosis and treatment, disease prevention, primary healthcare, traditional Chinese medicine services, childcare and elderly care, medical management, and medical insurance scenarios. A multi-level, multi-modal, high-quality medical and health dataset covering the entire life cycle will be developed. Efforts will also accelerate the construction of Medical Health Digital Intelligence Innovation Labs, Medical Insurance Data Empowerment Labs, and Trusted Data Spaces for the Health and Medical Insurance industries.
Recently, the People's Government of Jiangsu Province issued the "Jiangsu Province 'Artificial Intelligence+' Action Plan," proposing to popularize intelligent medical and health services. It aims to promote the integration and application of large models in clinical diagnosis and treatment, disease prevention, primary healthcare, traditional Chinese medicine services, childcare and elderly care, medical management, and medical insurance scenarios. A multi-level, multi-modal, high-quality medical and health dataset covering the entire life cycle will be developed. Efforts will also accelerate the construction of Medical Health Digital Intelligence Innovation Labs, Medical Insurance Data Empowerment Labs, and Trusted Data Spaces for the Health and Medical Insurance industries.
Guangzhou Releases "AI+" Typical Case Collection, Details of 16 "AI+Medical" Projects Announced
Guangzhou Releases "AI+" Typical Case Collection, Details of 16 "AI+Medical" Projects Announced
To further implement the "AI+" initiative, promote the application of artificial intelligence technologies and industrial development, and uncover and promote a group of industry-typical application cases with high implementation value and strong demonstration effects, the Guangzhou Municipal Bureau of Industry and Information Technology guided the Guangzhou AI Computing Power Application and Industrial Development Alliance to carry out the collection work of "AI+" typical application cases in three batches during 2025. Recently, the Guangzhou Municipal Bureau of Industry and Information Technology officially released the "List of Typical 'AI+' Cases in Guangzhou, 2025" and the "Collection of Typical 'AI+' Cases in Guangzhou, 2025."
A total of 16 projects in the "AI + Healthcare" field were selected, including the ChatZOC Ophthalmology Large Model jointly launched by Sun Yat-sen University's Zhongshan Ophthalmic Center and Huawei, as well as the "Artificial Intelligence for Simulating RNA Structure and Function in Diseases" and "Self-improving Generative Foundation Model for Synthetic Medical Image Generation and Clinical Applications" from Guangzhou Laboratory.
To further implement the "AI+" initiative, promote the application of artificial intelligence technologies and industrial development, and uncover and promote a group of industry-typical application cases with high implementation value and strong demonstration effects, the Guangzhou Municipal Bureau of Industry and Information Technology guided the Guangzhou AI Computing Power Application and Industrial Development Alliance to carry out the collection work of "AI+" typical application cases in three batches during 2025. Recently, the Guangzhou Municipal Bureau of Industry and Information Technology officially released the "List of Typical 'AI+' Cases in Guangzhou, 2025" and the "Collection of Typical 'AI+' Cases in Guangzhou, 2025."
A total of 16 projects in the "AI + Healthcare" field were selected, including the ChatZOC Ophthalmology Large Model jointly launched by Sun Yat-sen University's Zhongshan Ophthalmic Center and Huawei, as well as the "Artificial Intelligence for Simulating RNA Structure and Function in Diseases" and "Self-improving Generative Foundation Model for Synthetic Medical Image Generation and Clinical Applications" from Guangzhou Laboratory.
To further implement the "AI+" initiative, promote the application of artificial intelligence technologies and industrial development, and uncover and promote a group of industry-typical application cases with high implementation value and strong demonstration effects, the Guangzhou Municipal Bureau of Industry and Information Technology guided the Guangzhou AI Computing Power Application and Industrial Development Alliance to carry out the collection work of "AI+" typical application cases in three batches during 2025. Recently, the Guangzhou Municipal Bureau of Industry and Information Technology officially released the "List of Typical 'AI+' Cases in Guangzhou, 2025" and the "Collection of Typical 'AI+' Cases in Guangzhou, 2025."
A total of 16 projects in the "AI + Healthcare" field were selected, including the ChatZOC Ophthalmology Large Model jointly launched by Sun Yat-sen University's Zhongshan Ophthalmic Center and Huawei, as well as the "Artificial Intelligence for Simulating RNA Structure and Function in Diseases" and "Self-improving Generative Foundation Model for Synthetic Medical Image Generation and Clinical Applications" from Guangzhou Laboratory.
Medical Informatization Project Bidding
Smart Healthcare Enhancement Initiative and Informatization Project (Phase I)
On January 9, 2026, the Baoding Municipal Health Commission (at the municipal level) released the "Change of Government Procurement Intent for January to December 2026." Procurement Requirements: To accelerate the construction of "Digital Baoding" in the health sector, focusing on building a big data center for the medical industry, improving hospital operation and management levels, and promoting the construction of medical consortia, the Baoding Municipal Health Commission plans to implement the Smart Healthcare Enhancement Initiative and Phase I of the Informatization Project under the Baoding Public Hospital Reform and High-Quality Development Demonstration Project. The funding source is the special fund for the Baoding Public Hospital Reform and High-Quality Development Demonstration Project. According to relevant government procurement regulations, the procurement intent for this project is hereby announced. Suppliers with relevant qualifications and implementation experience are welcome to actively participate. (Note: The final procurement requirements, budget amount, and implementation scope shall be subject to the official tender documents.) Budget Amount: 191.65 million yuan. Estimated Procurement Time: February 2026.
Xiong'an Xuanwu Hospital (New District Investment Part) Project Information Engineering (Phase I)
On January 9, 2026, Xiong'an Xuanwu Hospital released the "Xiong'an Xuanwu Hospital (New District Investment Section) Project Informatization Engineering (Phase I)" tender announcement, with a budget of 64,310,700 yuan. Procurement requirements: Based on the hospital’s existing construction, this project will comply with the overall requirements and deployment of China's new medical reform and smart hospital initiatives, strengthening and improving the construction of capabilities in three areas: smart healthcare, smart services, and smart management. By expanding and supplementing the functionality of "digital" and "information-based" information systems through new construction, it aims to meet the informatization-related requirements for a "Class A tertiary comprehensive hospital," enhancing medical service and management, medical quality and safety, technical level and efficiency. Based on the hospital information integration platform, the project will achieve interconnection between different business systems and establish a clinical data center, operational data center, and data applications for the hospital. Smart healthcare will focus on electronic medical records as the core and electronic physician orders as the driver to build an integrated diagnosis and treatment service model, improving the work efficiency of medical staff. Smart services will provide patients with diversified medical services through mobile and internet technologies, offering seamless online and offline, off-site to on-site medical services. Smart management will implement intelligent management of medical quality and hospital operations by building systems such as medical project cost management and HRP operational decision support, enabling managers to comprehensively and quickly grasp the overall operation of the hospital and provide data support for leadership and management decision-making.
On January 13, 2026, Yijishan Hospital of Wannan Medical College released the "January 2026 Government Procurement Intention." The procurement needs include various aspects such as smart healthcare, smart management, smart services, data applications, and supporting services. Budget amount: 46.9 million yuan. Estimated procurement time: March 2026.
Software Part of the Informatization Construction for Phase II of Guizhou Hospital Affiliated to Sun Yat-sen University
On January 15, 2026, the Affiliated Hospital of Guizhou Medical University released a procurement demand announcement for the "Software Part of the Informatization Construction for Phase II of the Guizhou Hospital of the First Affiliated Hospital of Sun Yat-sen University," with a budget of 42,410,000 yuan. Construction Requirements: This project should fully consider the future unified operation and management model of multiple hospital districts. Based on thorough research of the informatization construction in Phase I of the Guizhou Hospital of the First Affiliated Hospital of Sun Yat-sen University and the informatization construction at the Yunyan District of the Affiliated Hospital of Guizhou Medical University, it is required to achieve unified management of “one hospital, two districts,” including unified, real-time operation management, basic data management, business management, etc.
Healthcare Improvement Project for the Entire Wengyuan County in Shaoguan City, Guangdong Province - Information Construction Project for the Wengyuan County's Close-knit Medical Consortium Resource Sharing Center
Potential bidders for the "Overall Medical and Health Improvement Project in Wengyuan County, Shaoguan City, Guangdong Province – Information Construction Project of the Wengyuan County Close-knit Medical Consortium Resource Sharing Center" should obtain the tender documents from the Guangdong Provincial Government Procurement Website at https://gdgpo.czt.gd.gov.cn/ and submit their tender documents before 09:30 (Beijing Time) on February 3, 2026. Budget amount: 34,681,760.62 RMB.
Information Construction Project of the South Campus of Altay Regional People's Hospital
On December 3, 2025, the People's Hospital of Altay Prefecture, Xinjiang, released the "Government Procurement Intention for December 2025."
Procurement Requirements Function or Objective: Involves the purchase of software, interfaces, and supporting hardware devices related to the informatization construction of the South Campus.
Requirements to be met:
1) Full-featured: Covering all scenarios of medical services, patient care, and hospital management;
2) Advanced Technology: Gigabit network, virtualization platform, and Level-3 security system compliant with national standards;
3) Ensure the security of medical data and the stable operation of the system;
4) Interconnectivity: Achieve integration of in-hospital systems and connection with external platforms;
5) Sustainable Development: With good scalability, adaptable to the future needs of medical informatization development.
Budget Amount: 30 million yuan
Estimated Procurement Time: 2026 - 02
First Affiliated Hospital of Kunming Medical University Informationization Project
On January 16, 2026, the First Affiliated Hospital of Kunming Medical University released the "Government Procurement Intention from January 2026 to December 2026." Procurement requirements: AI computing power servers, intelligent medical insurance management systems, switches, and overall informatization construction for enhancing clinical specialty capabilities. Whether it is specifically aimed at small and medium-sized enterprises: No. Budget amount: 29.632 million yuan. Estimated procurement time: June 2026.
2025 Laifeng County People's Hospital Information Construction Project
On January 13, 2026, Hubei Branch of China Telecom Digital Intelligence Technology Co., Ltd. released the tender announcement for the "2025 Lai Feng County People's Hospital Informatization Construction Project," with a budget of 25,981,132.08 yuan (excluding tax).
The project is divided into three sections, and the maximum number of sections a bidder can win is: 1.
Section 1: System Basic Management, Outpatient Diagnostic Services, Emergency Diagnostic Services, Inpatient Diagnostic Services, Clinical Information System, Disinfection Supply Room Management System (Regional Version), Comprehensive Business Management;
Section 2: Installation and debugging of hyper-converged integrated machines, hyper-converged switches, enterprise-level distributed storage, distributed storage switches, IT racks, rack side panels, integrated UPS, core switches, routers, aggregation switches, access switches, and other equipment; technical service installation and debugging for domestically produced desktop computers and medical cloud desktop systems; technical services for remote desktop access control systems, server cryptographic machines, and collaborative signature servers; integration services for internal and external network aggregation operation and maintenance technology, etc.;
Section Three: Installation and debugging services for hyper-converged software, hyper-converged HCI, firewalls, situational awareness, database auditing and risk control systems, installation and debugging of related supporting facilities, technical service installation and debugging services, and AI computing power platform installation and debugging services.
The highest bid limit for Section One is 19,830,190.08 yuan (excluding tax).
The highest bid limit for Section 2 is 3,766,037.00 yuan (excluding tax).
The highest bid limit for Section Three is 2,384,905.00 yuan (excluding tax).
Abaga Banner People's Hospital (General Hospital) Medical Consortium Project
Potential bidders for the Abaga Banner People's Hospital (General Hospital) Medical Consortium Project should obtain the tender documents from the Inner Mongolia Autonomous Region Government Procurement Network (Government Procurement Cloud Platform) and submit their tender documents before 09:00 on February 6, 2026 (Beijing Time). Budget amount: 11.281191 million yuan.
Sunite Left Banner Close-knit County Medical Consortium Information Construction Project
Potential bidders for the Sunite Left Banner Close-knit County Medical Consortium Information Construction Project should obtain the tender documents from the Inner Mongolia Autonomous Region Government Procurement Network (Government Procurement Cloud Platform) and submit the tender documents before 09:00 (Beijing Time) on February 5, 2026. Budget amount: 5.85 million yuan.
Construction of the Qinyang County People's Hospital Close-knit Medical Community Information Platform
Potential bidders for the construction of an integrated medical consortium information platform should obtain the tender documents online and submit their bids by 09:00 on February 26, 2026 (Beijing Time). Budget amount: 3.57 million yuan.
Xiwu Zhu Mu Qin Banner Medical Consortium Platform and Supporting Information Construction Project (Cloud Service)
Potential suppliers for the Xiwu Zhu Mu Qin Banner Medical Consortium Platform and Supporting Information Construction Project (Cloud Service) should obtain the procurement documents from the Inner Mongolia Autonomous Region Government Procurement Network (Government Procurement Cloud Platform) and submit response documents before 09:00 on January 27, 2026 (Beijing Time). Budget Amount: 3.119593 million yuan.
Honghu Traditional Chinese Medicine Hospital Reform and High-Quality Development Project (Homogeneous Construction of Medical Consortium Information, Capacity Building of Traditional Chinese Medicine in Medical Consortium)
Potential bidders for the Honghu Traditional Chinese Medicine Hospital Reform and High-Quality Development Project (Standardization of Medical Consortium Information, Construction of TCM Capability in Medical Consortium) should obtain the tender documents by clicking on the file download link in the project announcement on the Hubei Provincial Government Procurement Electronic Trading Data Aggregation Platform (website: https://czt.hubei.gov.cn/zchj/user) Supplier Client. The tender documents must be submitted before 09:00 (Beijing Time) on February 3, 2026. Budget amount: RMB 2.93227 million.
Sui Ling County Medical Community Informatization Construction (Second Time)
Potential suppliers for the Suiling County Medical Consortium Information Construction (Second Time) procurement project should obtain the procurement documents during the announcement period by logging into the Heilongjiang Provincial Government Procurement Management Platform (http://hljcg.hlj.gov.cn/) with their username and password. Select "Transaction Execution - Tender - Project Bid", choose the project you wish to participate in from the "Unparticipated Projects" list, and confirm participation to access the procurement documents. Response documents must be submitted before 09:00 (Beijing Time) on January 26, 2026. Budget amount: 27 million yuan.
Kashgar City Medical Consortium Central Pharmacy (Prescription Review Center) Construction Project (Fifth Time)
Kashgar City Medical Consortium Central Pharmacy (Prescription Review Center) Construction Project (Fifth Time)Potential bidders should be inZhangcai Cloud Platform OnlineObtain the tender documents andFebruary 9, 2026 11:00 AM(Before Beijing Time) to submit the tender documents.Budget Amount:RMB 2 million.
Yangzhou City Medical Security Bureau Unified Medical Insurance Information System Operation and Maintenance Management Procurement Project in Jiangsu Province
Potential bidders for the Yangzhou Medical Security Bureau's procurement project of unified medical insurance information system operation and maintenance management in Jiangsu Province should obtain the tender documents from the "Su Cai Yun" system (URL: http://jszfcg.jsczt.cn/) and submit the tender documents before 09:30 (Beijing Time) on February 6, 2026. Budget amount: 1.8 million yuan.
Procurement Project for the Operation and Maintenance Services of the Medical Insurance Information System in 2026
Procurement Project for the Operation and Maintenance Services of the 2026 Medical Insurance Information SystemPotential suppliers should obtain the procurement documents on the Sichuan Provincial Government Procurement Integrated Platform Project Electronic Trading System andJanuary 28, 2026, 09:30 AMSubmit the response documents by (Beijing Time).Budget Amount: 1.3 million yuan.
Investment and Financing Dynamics
Surgical Innovation Completes Hundreds of Millions of Dollars in B+ Round Financing
In January 2026, Surinnovate, a medical technology company, announced the completion of a B+ round of financing worth hundreds of millions of RMB. This round of financing was jointly invested by the National SME Development Fund, Oriental Fortune, and existing shareholders. Surinnovate focuses on the research and development of artificial intelligence multimodal brain-computer interface systems, dedicated to exploring brain functions, neural repair, and the treatment and functional reconstruction of patients with stroke and brain injuries. The funds raised will be used to deepen the application of brain-computer interface technology in diverse industrial scenarios, promote the construction of an innovative ecosystem across the entire chain, and further advance its layout in the field of healthcare management solutions.
SenseTime Healthcare Secures Nearly RMB 100 Million in Strategic Investment
SenseTime Health is a provider of intelligent diagnosis and treatment solutions, focusing on the application of artificial intelligence technology in the medical field. The company has developed the SenseCare Intelligent Diagnosis and Treatment Platform, an AI-powered medical product prototype. This platform assists doctors in diagnosis, treatment planning, and rehabilitation recommendations, supporting anomaly detection, identification, and automated diagnostic analysis for multiple organs. It primarily serves key clinical departments such as radiology, pathology, radiotherapy, surgery, and orthopedics. Recently, SenseTime Health officially received nearly 100 million yuan in strategic investment from Henan Huirong Artificial Intelligence Industry Investment Fund, with Wincome Capital continuing to act as the financial advisor.
Shengsheng Ji Completes Tens of Millions of Yuan in Angel Round Financing
Shengsheng Ji is a smart health technology brand. Driven by AI and cutting-edge technologies, the company integrates Eastern health philosophies with modern engineering techniques. It focuses on home health monitoring and management, skin function repair and renewal, and emotional and mental health interventions, aiming to bring health technology from laboratories into daily life. Recently, Shengsheng Ji completed an angel round of strategic financing worth tens of millions of yuan, with participation from multiple leading strategic resource partners.
Painier Medical Completes A+ Round Financing
On January 12, 2026, Penir Medical, a high-end intelligent medical device company, announced the completion of its A+ round of financing. This round was led by Zhongguancun Venture Capital and Huafu Juneng Investment. The funds will be used to advance the research and clinical application of its CT-guided real-time puncture minimally invasive diagnosis and treatment robotic system. The company focuses on integrated tumor solutions, with core products applicable to percutaneous interventional diagnosis and treatment of thoracic and abdominal tumors, and extends to fields such as orthopedics and neurology. This financing will accelerate the company's technological iteration and market layout, enhancing its competitiveness in the intelligent surgical instruments field.
Painier Medical Completes A+ Round Financing
On January 12, 2026, Penir Medical, a high-end intelligent medical device company, announced the completion of its A+ round of financing. This round was led by Zhongguancun Venture Capital and Huafu Juneng Investment. The funds will be used to advance the research and clinical application of its CT-guided real-time puncture minimally invasive diagnosis and treatment robotic system. The company focuses on integrated tumor solutions, with core products applicable to percutaneous interventional diagnosis and treatment of thoracic and abdominal tumors, and extends to fields such as orthopedics and neurology. This financing will accelerate the company's technological iteration and market layout, enhancing its competitiveness in the intelligent surgical instruments field.
SurgScience Secures B+ Round Financing
Surgical Innovation Focuses on Minimally Invasive Surgical Core Technologies and Their Innovative Applications, Establishing Three Major Technology Platforms: Medical Metal Materials, Polymer Materials, and Artificial Intelligence Algorithms. It Has Developed Two Product Lines: Surgical Instruments and Surgical Consumables. The Company Successfully Addressed Key Technical Challenges Such as High-Performance Titanium Alloy Materials for Medical Use, High-Performance Piezoelectric Ceramic Materials, and Artificial Intelligence Ultrasonic Generator Algorithms, Launching an Intelligent Ultrasonic Surgical System and Several Innovative Implantable and Interventional Surgical Consumables. Surgical Innovation Secured B+ Round Financing, with Investment from the National Innovation Center.
SurgScience Secures B+ Round Financing
Surgical Innovation Focuses on Minimally Invasive Surgical Core Technologies and Their Innovative Applications, Establishing Three Major Technology Platforms: Medical Metal Materials, Polymer Materials, and Artificial Intelligence Algorithms. It Has Developed Two Product Lines: Surgical Instruments and Surgical Consumables. The Company Successfully Addressed Key Technical Challenges Such as High-Performance Titanium Alloy Materials for Medical Use, High-Performance Piezoelectric Ceramic Materials, and Artificial Intelligence Ultrasonic Generator Algorithms, Launching an Intelligent Ultrasonic Surgical System and Several Innovative Implantable and Interventional Surgical Consumables. Surgical Innovation Secured B+ Round Financing, with Investment from the National Innovation Center.
Mirror禾元康 Receives Angel Round Funding
MirrorHeal MetaHealth is an innovative company focused on AI-assisted minimally invasive surgical planning and navigation. Recently, MirrorHeal MetaHealth secured angel round funding from leading venture capital firms and the Jiangsu Industrial Technology Research Institute.
Mirror禾元康 Receives Angel Round Funding
MirrorHeal MetaHealth is an innovative company focused on AI-assisted minimally invasive surgical planning and navigation. Recently, MirrorHeal MetaHealth secured angel round funding from leading venture capital firms and the Jiangsu Industrial Technology Research Institute.
Merge Labs Secures $250 Million in Seed Funding
Merge Labs, a non-invasive brain-computer interface (BCI) company co-founded by Sam Altman and others, focuses on non-invasive neural connections based on ultrasound and molecular technologies. It aims to connect biological intelligence with artificial intelligence, covering scenarios such as medical rehabilitation and cognitive enhancement. Recently, Merge Labs secured $250 million in seed funding, with investment from the OpenAI Startup Fund.
Merge Labs Secures $250 Million in Seed Funding
Merge Labs, a non-invasive brain-computer interface (BCI) company co-founded by Sam Altman and others, focuses on non-invasive neural connections based on ultrasound and molecular technologies. It aims to connect biological intelligence with artificial intelligence, covering scenarios such as medical rehabilitation and cognitive enhancement. Recently, Merge Labs secured $250 million in seed funding, with investment from the OpenAI Startup Fund.
Tala Health Completes $100 Million Seed Financing Round
Tala Health, an AI healthcare company with remarkable commercial imagination, has recently completed a $100 million seed funding round led by Sofreh Capital, with participation from former Merck CEO Roy Vagelos. The company is now valued at $1.2 billion. Tala Health plans to use AI agent technology to reshape the fragmented healthcare system in the United States. It has already partnered with two major U.S. health insurance companies, aiming to provide patients with faster, more seamless, and more humanized medical services.
Tala Health Completes $100 Million Seed Financing Round
Tala Health, an AI healthcare company with remarkable commercial imagination, has recently completed a $100 million seed funding round led by Sofreh Capital, with participation from former Merck CEO Roy Vagelos. The company is now valued at $1.2 billion. Tala Health plans to use AI agent technology to reshape the fragmented healthcare system in the United States. It has already partnered with two major U.S. health insurance companies, aiming to provide patients with faster, more seamless, and more humanized medical services.
Proxima Secures $80 Million in Seed Funding
Proxima is an AI-driven drug discovery company dedicated to using machine learning to design and optimize induced proximity drugs. The company's evolutionary scoring system draws inspiration from naturally occurring protein interaction interfaces, enabling generative models to design smaller molecular glues that form highly cooperative ternary complexes. VantAI has collaborated with numerous biopharmaceutical partners to launch exciting new development projects through its unique "Protein-Contact-First" strategy, requiring only a fraction of the time and cost compared to traditional methods. Recently, Proxima secured $80 million in seed funding, led by DCVC Bio, with participation from Braidwell, Roivant, AIX Ventures, Yosemite, Magnetic Ventures, Alexandria Venture Investments, Modi Ventures, and NVentures.
Proxima Secures $80 Million in Seed Funding
Proxima is an AI-driven drug discovery company dedicated to using machine learning to design and optimize induced proximity drugs. The company's evolutionary scoring system draws inspiration from naturally occurring protein interaction interfaces, enabling generative models to design smaller molecular glues that form highly cooperative ternary complexes. VantAI has collaborated with numerous biopharmaceutical partners to launch exciting new development projects through its unique "Protein-Contact-First" strategy, requiring only a fraction of the time and cost compared to traditional methods. Recently, Proxima secured $80 million in seed funding, led by DCVC Bio, with participation from Braidwell, Roivant, AIX Ventures, Yosemite, Magnetic Ventures, Alexandria Venture Investments, Modi Ventures, and NVentures.
Converge Secures $25 Million in Series A Funding
On January 14, 2026, Converge, an AI-driven drug discovery service provider, announced the completion of a $25 million Series A financing round, jointly invested by BVP, TLV Partners, and other institutional and individual investors. The company is committed to advancing drug discovery innovation through its self-developed artificial intelligence platform, particularly in the field of antibody research. It employs unique data augmentation techniques to integrate critical information such as antigen-antibody interactions and protein interactions, while optimizing model performance based on clients' proprietary data. This round of financing will be used to accelerate platform technology iteration and team expansion, further solidifying its leading position in the AI-powered drug discovery sector.
Converge Secures $25 Million in Series A Funding
On January 14, 2026, Converge, an AI-driven drug discovery service provider, announced the completion of a $25 million Series A financing round, jointly invested by BVP, TLV Partners, and other institutional and individual investors. The company is committed to advancing drug discovery innovation through its self-developed artificial intelligence platform, particularly in the field of antibody research. It employs unique data augmentation techniques to integrate critical information such as antigen-antibody interactions and protein interactions, while optimizing model performance based on clients' proprietary data. This round of financing will be used to accelerate platform technology iteration and team expansion, further solidifying its leading position in the AI-powered drug discovery sector.
Ahead Health Secures $6 Million in Seed Funding
On January 14, 2026, Ahead Health, an AI-native health technology company, announced the completion of a $6 million seed funding round, invested by RTP Global. The company focuses on the research and development of AI-driven healthcare systems and provides preventive screening services. This round of funding will be used to accelerate product development, team expansion, and market outreach. This financing marks the continued attention from the capital market to the AI healthcare sector.
Ahead Health Secures $6 Million in Seed Funding
On January 14, 2026, Ahead Health, an AI-native health technology company, announced the completion of a $6 million seed funding round, invested by RTP Global. The company focuses on the research and development of AI-driven healthcare systems and provides preventive screening services. This round of funding will be used to accelerate product development, team expansion, and market outreach. This financing marks the continued attention from the capital market to the AI healthcare sector.
Pomelo Care Secures Series C Funding
On January 12, 2026, Pomelo Care, a U.S.-based virtual healthcare provider, announced the completion of its Series C financing round. This round was jointly participated in by several well-known investment institutions, including a16z, Atomico, BoxGroup, Plus Capital, Stripes Group, and SVA. The Series C funding will further accelerate Pomelo Care's expansion in the virtual healthcare sector, broaden its service scope and technological innovation, and provide high-quality medical services to more pregnant women and newborns.
Pomelo Care Secures Series C Funding
On January 12, 2026, Pomelo Care, a U.S.-based virtual healthcare provider, announced the completion of its Series C financing round. This round was jointly participated in by several well-known investment institutions, including a16z, Atomico, BoxGroup, Plus Capital, Stripes Group, and SVA. The Series C funding will further accelerate Pomelo Care's expansion in the virtual healthcare sector, broaden its service scope and technological innovation, and provide high-quality medical services to more pregnant women and newborns.
【AI Computing Power + Application Discussion Community】
By Invitation Only
Seat Locking: Exclusive Circle for Top Practitioners in AI Computing Power and AI Application Fields
√Obtain Exclusive Information on Hotspots and Frontier Industries of Medical AI Applications
√Stay informed about the latest regulatory and policy developments in the global medical AI field.
√In-depth Dialogue with AI Upstream and Downstream Enterprises
√Obtain First-Hand Global AI and Computing Power Industry Information
√Have the opportunity to participate in AI-themed industry exchange activities
Scan the code and leave a remark with the keyword [AI Joins the Group] Add Friend
Verify Identity (SendName/Company/Position）
Share
Favorite
Like
